🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the platform has removed violative content and prohibited related keywords and query recommendations. The organization said it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

After moments of entering one group, a vendor shared contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Item Information and Costs

Within these groups, messages show dark colored packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject users to potentially significant medical dangers”.